Abstract
Mental illnesses are affecting several millions of individuals in the U.S and worldwide. Statistics have revealed that one among six adults in the United States is suffering from a mental illness with varying severity. Accordingly, mental illnesses are considered as one of the major factors behind the global disability as well as health and economic burden. The conventional treatments prescribed to treat mood and mental disorders are observed to show a response in only 30-40% of patients with major depression disorder (MDD). Besides, the serious adverse events associated with these treatments have also made it urgent for scientists and researchers to search for other alternatives to be used as monotherapies or adjuvants to conventional treatments. In this review, we have summarized a number of the most extensively-studied natural remedies indicated for the treatment of anxiety and depression. We have also included some of the common nutraceuticals used to treat both anxiety and depression, along with a number of the newly-emerged adjuvant therapies.
Keywords: Herbal medicine, Nutraceuticals, Anxiety, Depression, Adjuvant therapy, Mental illness.
Graphical Abstract
Current Psychopharmacology
Title:Herbal Medication and Nutraceuticals for the Management of Anxiety and Depression
Volume: 7
Author(s): Sara Nidal Abed, Fatimah Amin Younes, Hiba Salim Surchi and Pran Kishore Deb*
Affiliation:
- Faculty of Pharmacy, Philadelphia University-19392, Amman,Jordan
Keywords: Herbal medicine, Nutraceuticals, Anxiety, Depression, Adjuvant therapy, Mental illness.
Abstract: Mental illnesses are affecting several millions of individuals in the U.S and worldwide. Statistics have revealed that one among six adults in the United States is suffering from a mental illness with varying severity. Accordingly, mental illnesses are considered as one of the major factors behind the global disability as well as health and economic burden. The conventional treatments prescribed to treat mood and mental disorders are observed to show a response in only 30-40% of patients with major depression disorder (MDD). Besides, the serious adverse events associated with these treatments have also made it urgent for scientists and researchers to search for other alternatives to be used as monotherapies or adjuvants to conventional treatments. In this review, we have summarized a number of the most extensively-studied natural remedies indicated for the treatment of anxiety and depression. We have also included some of the common nutraceuticals used to treat both anxiety and depression, along with a number of the newly-emerged adjuvant therapies.
Export Options
About this article
Cite this article as:
Abed Sara Nidal , Younes Fatimah Amin , Surchi Hiba Salim and Deb Kishore Pran *, Herbal Medication and Nutraceuticals for the Management of Anxiety and Depression, Current Psychopharmacology 2018; 7 (2) . https://dx.doi.org/10.2174/2211556007666180706155506
DOI https://dx.doi.org/10.2174/2211556007666180706155506 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
An Update of the Oxidation-Inflammation Theory of Aging: The Involvement of the Immune System in Oxi-Inflamm-Aging
Current Pharmaceutical Design An Agathokakological Tale of Δ<sup>9</sup>-THC: Exploration of Possible Biological Targets
Current Drug Targets Advances in Studies on Neurodegenerative Diseases and their Treatments
Current Topics in Medicinal Chemistry Targeting Neurotrophic/Growth Factor Expression and Signaling for Antidepressant Drug Development
CNS & Neurological Disorders - Drug Targets Ultramicronized Palmitoylethanolamide (um-PEA) as Add-on Treatment in Fibromyalgia Syndrome (FMS): Retrospective Observational Study on 407 Patients
CNS & Neurological Disorders - Drug Targets Pharmacotherapy and Prevention of Vascular Dementia
CNS & Neurological Disorders - Drug Targets TRPV1 Antagonists as a Potential Treatment for Hyperalgesia
Recent Patents on CNS Drug Discovery (Discontinued) Genetic Variation and Atherosclerosis
Current Genomics Atypical Major Depression - Past, Present, and Future
Current Psychiatry Reviews Nanotechnology in Neuroscience and its Perspective as Gene Carrier
Current Topics in Medicinal Chemistry The TLR9 Antagonist iCpG-ODN at Different Dosages Inhibits Cerebral Ischemia/Reperfusion Injury in Mice
CNS & Neurological Disorders - Drug Targets Contemporary Progress in the Synthesis and Reaction of 2-Arylbenzothiazole: A Review
Current Organic Chemistry Amyloid Beta Protein and Tau in Cerebrospinal Fluid and Plasma as Biomarkers for Dementia: A Review of Recent Literature
Current Clinical Pharmacology Preface
Central Nervous System Agents in Medicinal Chemistry Evaluation of Anti-inflammatory Nutraceuticals in LPS-induced Mouse Neuroinflammation Model: An Update
Current Neuropharmacology Editorial: Advances in Understanding Alzheimer's Disease, and the Contributions of Current Alzheimer Research: Ten Years on and Beyond
Current Alzheimer Research Speech Recognition Using Elman Artificial Neural Network and Linear Predictive Coding
Recent Advances in Computer Science and Communications Prothrombotic Potential of NSAID in Ischemic Heart Diesase
Mini-Reviews in Medicinal Chemistry PreQ<sub>0</sub> Base, an Unusual Metabolite with Anti-cancer Activity from Streptomyces qinglanensis 172205
Anti-Cancer Agents in Medicinal Chemistry MIANN Models in Medicinal, Physical and Organic Chemistry
Current Topics in Medicinal Chemistry